NY Hospital

Frank A. Petito, MD, received his medical degree M.D. from Columbia-Presbyterian Medical College. He completed his internship and residency training in neurology at The New York Hospital. He is certified by The American Board of Psychiatry and Neurology and was recently named as one of the top doctors in his field by New York Magazine. Dr. Petito is an expert in the diagnosis and treatment of all aspects of neurologic disorders. His particular interest lies in the areas of headache and Multiple Sclerosis. For Consultation/Referral/ Appointment please call: (212) 746-2309.

Dr. Justin Kaner graduated with a B.S. in Biology from Syracuse University in 2009 where his initial interest in hematologic malignancies developed. He received his M.D. from New York Medical College in 2013 before completing his Internal Medicine Residency at Albert Einstein College of Medicine/Montefiore Medical Center. During residency Dr. Kaner pursued his interest in hematologic malignancies by undertaking several research projects mainly focused on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) which led to several publications in peer reviewed journals, including Leukemia and Lymphoma and Oncotarget, as well as numerous abstracts presented at the American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) Annual Meetings. Additionally, Dr. Kaner served as Chief Resident after his residency at Montefiore Medical Center.Throughout his Hematology/Oncology fellowship at Weill Cornell Medicine and NewYork-Presbyterian Hospital, Dr. Kaner worked in the laboratory of Dr. Monica Guzman and with clinical mentorship from Dr. Ellen Ritchie and Dr. Gail Roboz of the Weill Cornell Leukemia Program. During this time, he studied the activity of a novel therapeutic, PU-H71, in PTPN11 mutated AML as well as the prognostic impact of PTPN11 mutations in AML. During his fellowship training Dr. Kaner also developed a particular interest in early phase clinical trials and novel therapeutics for the treatment of Relapsed/Refractory AML. Dr. Kaner accepted an opportunity to remain at Weill Cornell, joining the Leukemia Program to focus on caring for hospitalized patients with various acute and chronic leukemias, MDS and myeloproliferative neoplasms (MPNs).

Dr. Shmuel Chen is an Assistant Professor of Medicine at Weill Cornell Medicine and the NewYork-Presbyterian Hospital. He specializes in interventional cardiology including the treatment of coronary and structural heart disease.Dr. Chen received his medical degree from The Hebrew University School of Medicine (Jerusalem, Israel) as well as a PhD in Neurobiology from the Hebrew University School of Medicine. He completed his training in internal medicine and cardiology at the Hebrew University, Hadassah Medical Center (Jerusalem, Israel), where he also served as a Staff Cardiologist and a Lecturer in Cardiology. He subsequently moved to New York City and dedicated over 2 years to a prestigious research fellowship at the Cardiovascular Research Foundation (CRF). During this time, he worked towards designing and undertaking cutting-edge clinical trials and research in interventional cardiology. He has lead and extensively contributed to a number of projects and studies, exploring all aspects of cardiovascular and structural heart disease. These works have been published in leading medical journals in the field. After this focused research time, Dr. Chen joined The Columbia University Irving Medical Center and the NewYork-Presbyterian Hospital (New York, NY) for a two-year interventional cardiology fellowship program in July 2019. He gained specialty training in coronary interventions and strcutrual heart disease including aortic, mitral, tricuspid, paravalvular leak, patent foramen ovale (PFO), and left atrial appendage procedures. He joined the Weill Cornell Medical Center in September 2021 for another year of advanced structural heart training and served as an Instructor in Medicine.